| 000 | 07389nam a22004813i 4500 | ||
|---|---|---|---|
| 001 | EBC3018565 | ||
| 003 | MiAaPQ | ||
| 005 | 20240729124104.0 | ||
| 006 | m o d | | ||
| 007 | cr cnu|||||||| | ||
| 008 | 240724s2008 xx o ||||0 eng d | ||
| 020 |
_a9781607410904 _q(electronic bk.) |
||
| 020 | _z9781606920664 | ||
| 035 | _a(MiAaPQ)EBC3018565 | ||
| 035 | _a(Au-PeEL)EBL3018565 | ||
| 035 | _a(CaPaEBR)ebr10660426 | ||
| 035 | _a(OCoLC)839305400 | ||
| 040 |
_aMiAaPQ _beng _erda _epn _cMiAaPQ _dMiAaPQ |
||
| 050 | 4 | _aRC682 -- .H3836 2009eb | |
| 082 | 0 | _a616.1/20082 | |
| 100 | 1 | _aLardner, Benjamin V. | |
| 245 | 1 | 0 | _aHeart Disease in Women. |
| 250 | _a1st ed. | ||
| 264 | 1 |
_aNew York : _bNova Science Publishers, Incorporated, _c2008. |
|
| 264 | 4 | _c©2009. | |
| 300 | _a1 online resource (285 pages) | ||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 505 | 0 | _aIntro -- HEART DISEASE IN WOMEN -- Contents -- Preface -- Chapter I Cardiac Rehabilitation: Secondary Prevention of Cardiovascular Disease in Women -- Abstract -- Introduction -- Gender Differences in Cardiac Risk Factors -- Smoking -- Dyslipidemia -- Diabetes Mellitus -- Hypertension -- Obesity -- Depression -- Gender Differences in Diagnosis of Cardiovascular Disease -- Gender Differences in Prevention of Cardiovascular Disease -- Cardiac Rehabilitation Programs -- Gender Differences in Utilization of Cardiac Rehabilitation -- Gender Differences on Entry to a Cardiac Rehabilitation Program -- Gender Differences in Clinical Outcome in Cardiac Rehabilitation -- Morbidity and Mortality -- Diabetes Mellitus -- Lipids -- Obesity -- Depression -- Hypertension -- Conclusion -- References -- Chapter II Effects of Estrogen and its Receptors on Myocardial Infarction -- Abstract -- 1. Estrogen and Heart Failure Post-MI -- 1.1. Estrogen and Inflammation -- 1.2. Estrogen and Apoptosis -- 1.2.1. The Effect of Estrogen on Anti-Apoptosis System -- 1.2.2. The Effect of Estrogen on Apoptosis System -- 1.3. Estrogen and EPCs -- 1.4. Estrogen and Cardiac Hypertrophy -- 1.4.1. Role of ERs in Cadiocyte Hypertrophy -- 1.4.2. Anti-Hypertrophy Pathway Induced by Estrogen -- 2. Estrogen and Arrhythmia Post-MI -- 2.1. Estrogen and Neural Remodeling -- 2.2. Estrogen and Electrical Remodeling -- 2.2.1. Activating ATP-sensitive Potassium (KATP) Channels -- 2.2.2. Inhibiting Calcium Channels -- 2.2.3. Down-regulating Kv4.3 Expression -- 2.3. Estrogen and Structural Remodeling -- References -- Chapter III Preeclampsia and Risk of Cardiovascular Disease: Epidemiology and Pathophysiology -- Preeclampsia: Definition and Epidemiology -- Preeclampsia: Pathogenesis -- Preeclampsia and Cardiovascular Disease -- Inflammation as the Possible Link between CVD and PE. | |
| 505 | 8 | _aThe Infectious Hypothesis -- Clinical and Research Implications -- References -- Chapter IV Diabetes and the Risk of Coronary Heart Disease among Women -- Abstract -- 1. Diabetes and Women's CHD Risk -- 2. The Magnitude of the Effect of Diabetes and Myocardial Infarction on Women's CHD Risk -- Conclusion -- References -- Chapter V The Impact of Heart Rate as a Cardiovascular Risk -- Abstract -- Introduction -- 1. Heart Rate as a Predictor of Risk for Cardiovascular Disorders: Epidemiologic Observations -- 2. Risk of Elevated Heart Rate on Cardiovascular Mortality in General Population -- Risk of Elevated Heart Rate for Hypertension and in the Elderly -- Recent Epidemiologic Data Relating Heart Rate and Outcome -- Gender Difference -- Heart Rate and Cardiovascular Risk Factors, Risk Stratification -- Pathophysiologic Mechanisms -- Heart Rate-Lowering Therapy -- Conclusion -- References -- Chapter VI Women in a World of Men's Disease: The Case of Female Cardiac Patients -- Abstract -- Introduction -- Gender Differences in the Response to Heart Disease -- Purpose of Study -- Design -- Sample -- Methods -- Analysis of Data -- Findings -- Discussion -- References -- Chapter VII Thromboembolism and Coronary Heart Disease: In Which Aspects are Women Different? -- Abstract -- Introduction -- Background -- Particularities of Anatomy, Physiology and Biomechanics in Women -- Pharmacogenetics, Pharmacokinetics and Pharmacodynamics of Cardiovascular Drugs in Women -- Influence of Estrogen on the Coagulation System -- Influence of Estrogen on the Endothelial Function -- Manifestatiosn of Thromboembolism and Arteriosclerosis -- Arterial Thromboembolism -- Therapeutic Consequences -- Anticoagulation -- Thrombolysis -- Screening before Oral Contraceptives -- Hormone Replacement Therapy (HRT) -- Betablockers -- ACE Inhibitors -- Conclusion. | |
| 505 | 8 | _aAcknowledgments -- References -- Chapter VIII Aging Women and Coronary Heart Disease -- Abstract -- Abbreviations and Acronyms -- Introduction -- Epidemiology and Prognosis of CHD in Women -- Menopause -- Cardiovascular Risk Factors in Women -- Framingham Risk Score for Women -- Clinical Features (Clinical Manifestations) and Outcome -- Noninvasive Tests in the Diagnosis of CHD in Women -- Case Report 1. (EC 77 Years Old) -- Invasive Diagnostic Procedures (Coronary Angiography) -- Management of Coronary Heart Disease in Women -- Recommendations for Management of Cardiovascular Risk in Women -- Medical Treatment -- Case Report 2. (IK 78 Years Old) -- Hormone Replacement Therapy and CHD -- Case Report 3. (ZD 58 Years Old) -- Invasive Procedures -- Percutaneous Coronary Intervention -- Case Report 4. (DG 76 Years Old) -- Bypass Surgery -- Case Report 5. (ZG 81 Years Old) -- Pregnancy and CHD -- Conclusion -- References -- Chapter IX Prognosis of Women with Acute Coronary Syndromes: An Overview -- Abstract -- Introduction -- Definition and Clasification of Acute Coronary Syndromes (ACS) -- Epidemiology of ACS -- The Outcome and Prognosis of ACS in Women and Comparison to Men -- What Are the Reasons for Differences in Outcome between the Genders? -- Conclusions -- References -- Chapter X The Effects of Aging on the Electrophysiological Properties of the Atrial Myocardium in Women with and without Paroxysmal Atrial Fibrillation -- Abstract -- Introduction -- Material and Methods -- Study Patients -- Electrophysiologic Study -- Definitions -- Data Analysis -- Results -- The Influence of Age in Group I -- The Influence of Age in Group II -- Discussion -- Conclusions -- References -- Chapter XI Women and Angina Pectoris: Emergency Department and Diagnostic Difficulties in an Undeveloped Community -- Abstract -- Introduction. | |
| 505 | 8 | _aMethods and Results -- Discussion -- Conclusion -- References -- Index. | |
| 588 | _aDescription based on publisher supplied metadata and other sources. | ||
| 590 | _aElectronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. | ||
| 650 | 0 | _aHeart diseases in women. | |
| 650 | 0 | _aInternal medicine. | |
| 655 | 4 | _aElectronic books. | |
| 700 | 1 | _aPennelton, Harrison R. | |
| 776 | 0 | 8 |
_iPrint version: _aLardner, Benjamin V. _tHeart Disease in Women _dNew York : Nova Science Publishers, Incorporated,c2008 _z9781606920664 |
| 797 | 2 | _aProQuest (Firm) | |
| 856 | 4 | 0 |
_uhttps://ebookcentral.proquest.com/lib/orpp/detail.action?docID=3018565 _zClick to View |
| 999 |
_c59748 _d59748 |
||